654 Results

People

  1. Motzer
    Motzer
  2. Mulhall
    Mulhall
  3. Saltz
    Saltz
  4. Hudis
    Hudis
  5. Abou-Alfa
    Abou-Alfa
  6. Lichtman
    Lichtman
  7. De Angelis
    De Angelis
  8. Ginsberg
    Ginsberg
  9. Russo
    Russo
  10. Feldman
    Feldman

Groups

  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)
  7. Division of Subspecialty Medicine (78)
  8. Center for Hematologic Malignancies (77)
  9. Epidemiology and Biostatistics (69)
  10. Radiology, Department of (61)
  1. "hypertension"
Formats
  1. Journal Article (607)
  2. Review (31)
  3. Editorial (6)
  4. Guidelines (4)
  5. Research Letter (3)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Correspondence (1)
Groups
  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)

More Groups

People
  1. Robert Motzer (59)
  2. John Mulhall (21)
  3. Leonard Saltz (18)
  4. Clifford Hudis (16)
  5. Richard Steingart (14)
  6. Ghassan Abou-Alfa (13)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (31)
  4. 2022 (29)
  5. 2021 (23)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Clinical Cancer Research (20)
  3. Lancet Oncology (20)
  4. Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (15)
  6. Journal of Sexual Medicine (14)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Elsevier Science, Inc. (58)
  3. Springer (47)
  4. American Society of Clinical Oncology (42)
  5. Oxford University Press (39)
  6. Wiley Blackwell (35)

More Publishers

Results (654)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Haas, N. B.; Donskov, F.; Gross-Goupil, M.; Varlamov, S.; Kopyltsov, E.; Lee, J. L.; Melichar, B.; Rini, B. I.; Choueiri, T. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors
    Journal Article

    Salz, T.; Zabor, E. C.; de Nully Brown, P.; Oksberg Dalton, S.; Raghunathan, N. J.; Matasar, M. J.; Steingart, R.; Vickers, A. J.; Munksgaard, P. S.; Oeffinger, K. C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
    Journal Article

    Voss, M. H.; Hussain, A.; Vogelzang, N.; Lee, J. L.; Keam, B.; Rha, S. Y.; Vaishampayan, U.; Harris, W. B.; Richey, S.; Randall, J. M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Haploinsufficiency of the transcription factor Ets-1 Is renoprotective in Dahl salt-sensitive rats
    Journal Article

    Feng, W.; Chen, B.; Xing, D.; Li, X.; Fatima, H.; Jaimes, E. A.; Sanders, P. W.
    Journal of the American Society of Nephrology (2017)

    Fulltext@MSK | Save
  • Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update
    Journal Article

    Hanna, N.; Johnson, D.; Temin, S.; Baker, S. Jr; Brahmer, J.; Ellis, P. M.; Giaccone, G.; Hesketh, P. J.; Jaiyesimi, I.; Leighl, N. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Genetic predisposition to bevacizumab-induced hypertension
    Journal Article

    Frey, M. K.; Dao, F.; Olvera, N.; Konner, J. A.; Dickler, M. N.; Levine, D. A.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Biochemical control during long-term follow-up of 230 adult patients with Cushing disease: A multicenter retrospective study
    Journal Article

    Geer, E. B.; Shafiq, I.; Gordon, M. B.; Bonert, V.; Ayala, A.; Swerdloff, R. S.; Katznelson, L.; Lalazar, Y.; Manuylova, E.; Pulaski-Liebert, K. J.; more...
    Endocrine Practice (2017)

    Fulltext@MSK | Save
  • Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer
    Journal Article

    Dolan, M. E.; Charif, O. E.; Wheeler, H. E.; Gamazon, E. R.; Ardeshir-Rouhani-Fard, S.; Monahan, P.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Treatment of gastrointestinal stromal tumours in paediatric and young adult patients with sunitinib: A multicentre case series
    Journal Article

    Rutkowski, P.; Magnan, H.; Chou, A. J.; Benson, C.
    BMC Cancer (2017)

    Fulltext@MSK | Save
  • Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Journal Article

    Kim, S. B.; Dent, R.; Im, S. A.; EspieĢ, M.; Blau, S.; Tan, A. R.; Isakoff, S. J.; Oliveira, M.; Saura, C.; Wongchenko, M. J.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save